Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00089115 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Stopped Withdrawn as company has shut down and filed for bankruptcy

Conditions

Lymphoma

Interventions

BIOLOGICAL: autologous immunoglobulin idiotype-KLH conjugate vaccine
BIOLOGICAL: rituximab
BIOLOGICAL: sargramostim

Sponsor

Favrille